Immunogenicity and protective efficacy of virosome based vaccines against Newcastle disease

Tropical Animal Health and Production

Volumn 42, Issue 3, 2010, Pages 465-471

  Singh, Rajinder ^a   Verma, Prem C ^a   Singh, Satparkash ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Chickens; Newcastle disease; PLG microsphere; Virosome

Indexed keywords

AVES; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

VIROSOME VACCINE; VIRUS VACCINE;

ANIMAL; ARTICLE; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; IMMUNOLOGY; NEWCASTLE DISEASE; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; CHICKENS; NEWCASTLE DISEASE; VACCINES, VIROSOME; VIRAL VACCINES;

EID: 77951648840     PISSN: 00494747     EISSN: 15737438     Source Type: Journal    
DOI: 10.1007/s11250-009-9444-2     Document Type: Article

References (36)

1. Alexander, D. J., 2001. Newcastle disease, Br. Poult. Sci., 42, 5-22.
2. Bachmann, M. F., Rohrer, U. H., Kundig, T. M., Burki, K., Hengartner, H. and Zinkernagal, R. M., 1993. The influence of antigenic organization on B cell responsiveness, Science, 262, 1448-1451.
3. Bagai, S. and Sarkar, D. P., 1993. Reconstituted Sendai virus envelopes as biological carriers: dual role of F protein in binding and fusion with liver cells, Biochem. Biophys. Acta., 1152, 15-25.
4. Bovier, P. A., 2008. Epaxal: a virosomal vaccine to prevent hepatitis A infection, Expert Rev. Vaccines, 7, 1141-1150.
5. Bron, R., Ortiz, A., Dijkstra, J., Stegmann, T. and Wilschut, J., 1993. Preparation, properties and applications of reconstituted influenza virus envelopes (virosomes), Meth. Enzymol., 220, 313-331.
6. Cannon, M. J. and Russel, P. H., 1988. Secondary in vitro stimulation of specific cytotoxic cells to Newcastle disease virus in chickens, Avian Pathol., 15, 731-740.
7. Chung, Y. C., Ho, M. S., Wu, J. C., Chen, W. J., Huang, J. H., Chou, S. T. and Hu, Y. C., 2008. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge, Vaccine, 26, 1855-1862.
8. de Mare, A., Bungener, L. B., Regts, J., de Vries-Idema, J., van der, A. G., Wilschut, J. and Daemen, T., 2008. The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity, Vaccine, 26, 2314-2321.
9. Droual, R., Bickford, A. A., Charlton, B. R. and Kuney, D. R., 1990. Investigation of problems associated with intramuscular breast injection of oil-adjuvanted killed vaccines in chickens, Avian Dis., 34, 571-574.
10. Durrer, P., Glück, U., Spyr, C., Lang, A. B., Zurbriggen, R., Herzog, C. and Glück, R., 2003. Mucosal antibody response induced with a nasal virosome-based influenza vaccine, Vaccine, 21, 4328-4334.
11. Eldridge, J. H., Meulbrock, J. A., Stass, J. K., Tice, T. R. and Gilley, R. M., 1991. Biodegradable and biocompatible poly-lactide-co-glycolide microspheres as an adjuvant for Staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies, Infect. Immun., 59, 2978-2986.
12. Garcia-Sastre, A., Cabezas, J. A. and Villar, E., 1989. Proteins of Newcastle disease virus envelope: interaction between the outer hemagglutination neuraminidase glycoprotein and the inner non-glycosylated matrix protein, Biochem. Biophys. Acta., 999, 171-175.
13. Goddard, R. D., Nicholas, R. A. J. and Luff, P. R., 1988. Serological based potency test for inactivated Newcastle disease vaccines, Vaccine, 6, 530-532.
14. Grimaldi, S., Giuliani, A., Ferroni, L., Lisi, A., Santoro, N., Pozzi, D., 1995. Engineered liposomes and virosomes for delivery of macromolecules, Res. Virol., 146, 289- 293.
15. Hawkes, R. A., Darbyshire, J. H. and Peters, R. W., 1983. Presence of viral antigens and antiody in the trachea of chickens infected with avian infectious bronchitis virus Avian Path., 12, 331-340.
16. Homhuan, A., Prakongpan, S., Prachak, P., Maas, R. A., Crommelin, D. J. A., Kersten, G. F. A. and Jiskoot, W., 2004. Virosome and ISCOM vaccines against Newcastle disease: preparation, characterization and immunogenicity, E. J. Pharm. Sci., 22, 459-468.
17. Huckriede, A., Bungener, L., ter Veer, W., Holtrop, M., Daemen, T., Palache, A. M. and Wilschut, J., 2003. Influenza virosomes: combining optimal presentation of hemagglutinin immunopotentiating activity, Vaccine, 21, 925-931.
18. Kapczynski, D. R. and King, D. J., 2005. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak, Vaccine, 23, 3424-3433.
19. Kapczynski, D. R. and Tumpey, T. M., 2003. Development of a virosome vaccine for Newcastle disease virus, Avian Dis., 47, 578-587.
20. Laemmli, V. K., 1970. Cleavage of structural proteins during the assembly of head of bacteriophage T4, Nature, 227, 680-684.
21. LoBue, A. D., Thompson, J. M., Lindesmith, L., Johnston, R. E. and Baric, R. S., 2009. Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge, J. Virol., 83, 3212-3227.
22. Maas, R., Komen, M., van Diepen, M., Oei, H. and Classen, I. J. T. M., 2003. Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines, Vaccine, 21, 3137-3142.
23. Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays, J. Immunol. Meth., 65, 55-63.
24. O'Hagan, D. T., Singh, M., Ugozzoli, M., Wild, C., Barnett, S., Chen, M., Schaefer, M., Doe, B., Otten, G. R. and Ulmer, J. B., 2001. Induction of potent immune responses by cationic microparticles with Adsorbed Human Immunodeficiency virus DNA vaccines, J. Virol., 75, 9037-9043.
25. Quan, F. S., Steinhauer, D., Huang, C., Ross, T. M., Compans, R. W. and Kang, S. M., 2008. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs, Vaccine, 26, 3352-3361.
26. Ramya, R., Verma, P. C., Chaturvedi, V. K., Gupta, P. K., Pandey, K. D., Madhanmohan, M., Kannaki, T. R., Sridevi, R. and Anukumar, B., 2009. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus, Vaccine, 27, 2138-2143.
27. Rao, M., Bray, M., Alving, C. R., Jahrling, P. and Matyas, G. R., 2002. Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells, J. Virol., 76, 9176-9185.
28. Reed, L. J. and Muench, H., 1938. A simple method for estimating fifty percent end points, Am. J. Hyg., 27, 439-497.
29. Reynold, D. L. and Maraqa, A. D., 2000. Protective immunity against Newcastle disease: The role of cell-mediated immunity, Avian Dis., 44, 145-154.
30. Rosas, J. E., Hernandez, A. R., Gascon, M., Igartua, F., Guzman, M. E. and Patarroyo, J. L., 2001. Biodegradable PLG microspheres as a delivery system for malaria synthetic peptide SPF 66, Vaccine, 19, 4445-4451.
31. Setti, M., Fenoglio, D., Ansaldi, F., Filaci, G., Bacilieri, S., Sticchi, L., Ferrera, A., Indiveri, F. and Ghio, M., 2009. Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients, Vaccine, 27, 3367-3372.
32. Speth, C., Bredl, S., Hagleitner, M., Wild, J., Dierich, M., Wolf, H., Schroeder, J., Wagner, R. and Deml, L., 2008. Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes, Virology, 382, 46-58.
33. Westbury, H., 2001. Newcastle disease virus: an evolving pathogen? Avian Path., 30, 117-128.
34. Wilschut, J., 2009. Influenza vaccines: the virosome concept, Immunol. Lett., 122, 118-121.
35. Yamanaka, M., Okabe, T., Nakai, M. and Goto, N., 1993. Local pathological reactions and immune response of chickens to ISA-70 and other adjuvants containing Newcastle disease virus antigen, Avian Dis., 37, 459-466.
36. Yusoff, K. and Tan, W. S., 2001. Newcastle disease virus: macromolecules and opportunities, Avian Path., 30, 439-455.